Codman Cranial Access Kits- indicated when a craniotomy is required for placement of an intracran...
FDA Device Recall #Z-0817-2022 — Class II — January 21, 2022
Recall Summary
| Recall Number | Z-0817-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 21, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Integra LifeSciences Corp. |
| Location | Princeton, NJ |
| Product Type | Devices |
| Quantity | 1161 kits |
Product Description
Codman Cranial Access Kits- indicated when a craniotomy is required for placement of an intracranial pressure (ICP) monitoring device and/or cerebrospinal fluid drainage procedures. Product umber: 826614
Reason for Recall
Incorrect extended expiration dates identified on the outer box label only, if product is used past the correct expiration date there is a potential for pain, infection, or adverse tissue reaction to occur
Distribution Pattern
Worldwide distribution - US Nationwide and the country of Hong Kong.
Lot / Code Information
Lot Numbers: 20LDC222, 21HDC461 UDI# 10381780520375
Other Recalls from Integra LifeSciences Corp.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1295-2025 | Class II | AURORA Surgiscope System, Sterile, single use d... | Feb 6, 2025 |
| Z-1168-2025 | Class II | Brand Name: MediHoney¿ Gel Product Name: MediH... | Jan 10, 2025 |
| Z-0977-2025 | Class II | CODMAN CERTAS Plus Programmable Valve Inline Sm... | Dec 16, 2024 |
| Z-0978-2025 | Class II | CODMAN CERTAS Plus Programmable Valve Inline Sm... | Dec 16, 2024 |
| Z-0979-2025 | Class II | CODMAN CERTAS Plus Programmable Valve Right Ang... | Dec 16, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.